Page last updated: 2024-10-25

ciprofibrate and Coronary Disease

ciprofibrate has been researched along with Coronary Disease in 5 studies

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"Dyslipidaemia in patients with type 2 diabetes commonly consists of elevated triglyceride levels; normal or slightly elevated low-density lipoprotein (LDL)-cholesterol levels with a preponderance of small, dense LDL particles; and low high-density lipoprotein (HDL)-cholesterol levels with a preponderance of small, dense HDL."2.42LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit? ( Taskinen, MR, 2003)
"Fibric acid derivatives may interact with other drugs and the interactions can be of clinical relevance."2.39Drug interactions with fibric acids. ( Dujovne, CA; Lozada, A, 1994)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taskinen, MR1
Schonfeld, G1
Lozada, A1
Dujovne, CA1
Kontopoulos, AG2
Athyros, VG2
Papageorgiou, AA2
Hatzikonstandinou, HA1
Mayroudi, MC1
Boudoulas, H1

Reviews

3 reviews available for ciprofibrate and Coronary Disease

ArticleYear
LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?
    Diabetes research and clinical practice, 2003, Volume: 61 Suppl 1

    Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Controlled Clinical Trials as

2003
The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
    Atherosclerosis, 1994, Volume: 111, Issue:2

    Topics: Arteriosclerosis; Bezafibrate; Blood Coagulation; Clofibric Acid; Coronary Disease; Fenofibrate; Fib

1994
Drug interactions with fibric acids.
    Pharmacology & therapeutics, 1994, Volume: 63, Issue:2

    Topics: Anticoagulants; Bezafibrate; Clofibrate; Clofibric Acid; Contraceptives, Oral; Coronary Disease; Dru

1994

Trials

2 trials available for ciprofibrate and Coronary Disease

ArticleYear
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
    Coronary artery disease, 1996, Volume: 7, Issue:11

    Topics: Adult; Analysis of Variance; Clofibric Acid; Coronary Disease; Double-Blind Method; Drug Therapy, Co

1996
Statin-fibrate combinations in patients with combined hyperlipedemia.
    Atherosclerosis, 2001, Volume: 155, Issue:1

    Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfib

2001